Loading…
The success of dietary protein restriction in alkaptonuria patients is age‐dependent
Alkaptonuria is characterized by an increased urinary excretion of homogentisic acid, pigmentation of cartilage and connective tissues, and ultimately the development of inflammatory arthropathy. Various diets low in protein have been designed to decrease homogentisic acid excretion and to prevent t...
Saved in:
Published in: | Journal of inherited metabolic disease 1998-12, Vol.21 (8), p.791-798 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3671-ca68047b02ed7e718afffcbda4f02bc78f487b14990433c62810970521a615ea3 |
---|---|
cites | cdi_FETCH-LOGICAL-c3671-ca68047b02ed7e718afffcbda4f02bc78f487b14990433c62810970521a615ea3 |
container_end_page | 798 |
container_issue | 8 |
container_start_page | 791 |
container_title | Journal of inherited metabolic disease |
container_volume | 21 |
creator | Haas, V. Carbasius Weber, E. C. Klerk, J. B. C. Bakker, H. D. Smit, G. P. A. Huijbers, W. A. R. Duran, M. Poll‐The, B. T. |
description | Alkaptonuria is characterized by an increased urinary excretion of homogentisic acid, pigmentation of cartilage and connective tissues, and ultimately the development of inflammatory arthropathy. Various diets low in protein have been designed to decrease homogentisic acid excretion and to prevent the ochronotic pigmentation and arthritic lesions. However, limited information is available on the long‐term beneficial effects of these diets. We reviewed the medical records of 16 patients aged 3–27 years (4>18 years) to ascertain the age of diagnosis, growth, development, social behaviour, signs of complications and longitudinal dietary compliance. The diagnosis of alkaptonuria was made at an average age of 1.4 years (2 months–4 years); following the diagnosis all patients were prescribed a diet with a protein content of 1.5 g/kg per day. All patients showed normal growth and development, and no major complications of the disease. Behavioural problems associated with poor dietary compliance emerged as the main problem. Dietary compliance decreased progressively with age. The effect of dietary protein restriction in homogentisic acid excretion was studied by fixing the amounts of protein in the diet at 1 g/kg per day and 3.5–5 g/kg per day during 8 days. Twelve patients, aged 4–27 years, participated in the investigation. Protein restriction resulted in a significantly lower excretion of homogentisic acid in the urine of children younger than 12 years (p |
doi_str_mv | 10.1023/A:1005410416482 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69111675</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69111675</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3671-ca68047b02ed7e718afffcbda4f02bc78f487b14990433c62810970521a615ea3</originalsourceid><addsrcrecordid>eNqFkM9u1EAMxkcIVLaFMyekOSBuofZk_oXbqrRQVMSlcI0mEw8MZJMwkwj11kfoM_IkDNoViFNPlu2fP9sfY88QXiGI-nT7GgGURJCopRUP2AaVqSuhtXrINoASK9so9Zgd5_wNABqr1BE7aqwBAXLDPl9_JZ5X7ylnPgXeR1pcuuFzmhaKI0-UlxT9EqeRl9QN3928TOOaouOzWyKNS-Yxc_eFft3e9TTT2JfaE_YouCHT00M8YZ8uzq_P3lVXH99enm2vKl9rg5V32oI0HQjqDRm0LoTgu97JAKLzxgZpTYeyaUDWtdfCIjQGlECnUZGrT9jLvW6598dabm13MXsaBjfStOZWN4iojSrg6R70aco5UWjnFHfl0xah_eNku23_c7JMPD9Ir92O-r_8wbrSf3Hou-zdEJIbfcz_ZLWRosaCqT32Mw50c9_W9v3lhzdgGqx_AzXlizA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69111675</pqid></control><display><type>article</type><title>The success of dietary protein restriction in alkaptonuria patients is age‐dependent</title><source>Wiley-Blackwell Read & Publish Collection</source><source>Springer Nature - Connect here FIRST to enable access</source><creator>Haas, V. ; Carbasius Weber, E. C. ; Klerk, J. B. C. ; Bakker, H. D. ; Smit, G. P. A. ; Huijbers, W. A. R. ; Duran, M. ; Poll‐The, B. T.</creator><creatorcontrib>Haas, V. ; Carbasius Weber, E. C. ; Klerk, J. B. C. ; Bakker, H. D. ; Smit, G. P. A. ; Huijbers, W. A. R. ; Duran, M. ; Poll‐The, B. T.</creatorcontrib><description>Alkaptonuria is characterized by an increased urinary excretion of homogentisic acid, pigmentation of cartilage and connective tissues, and ultimately the development of inflammatory arthropathy. Various diets low in protein have been designed to decrease homogentisic acid excretion and to prevent the ochronotic pigmentation and arthritic lesions. However, limited information is available on the long‐term beneficial effects of these diets. We reviewed the medical records of 16 patients aged 3–27 years (4>18 years) to ascertain the age of diagnosis, growth, development, social behaviour, signs of complications and longitudinal dietary compliance. The diagnosis of alkaptonuria was made at an average age of 1.4 years (2 months–4 years); following the diagnosis all patients were prescribed a diet with a protein content of 1.5 g/kg per day. All patients showed normal growth and development, and no major complications of the disease. Behavioural problems associated with poor dietary compliance emerged as the main problem. Dietary compliance decreased progressively with age. The effect of dietary protein restriction in homogentisic acid excretion was studied by fixing the amounts of protein in the diet at 1 g/kg per day and 3.5–5 g/kg per day during 8 days. Twelve patients, aged 4–27 years, participated in the investigation. Protein restriction resulted in a significantly lower excretion of homogentisic acid in the urine of children younger than 12 years (p<0.01), whereas this effect was less obvious for adolescent and adult patients. The results suggest that restriction of protein intake may have a beneficial effect on alkaptonuric children; but continuation of this regimen to older age seems questionable and not practical.</description><identifier>ISSN: 0141-8955</identifier><identifier>EISSN: 1573-2665</identifier><identifier>DOI: 10.1023/A:1005410416482</identifier><identifier>PMID: 9870204</identifier><identifier>CODEN: JIMDDP</identifier><language>eng</language><publisher>Dordrecht: Kluwer Academic Publishers</publisher><subject>Adolescent ; Adult ; Aging ; Alkaptonuria - complications ; Alkaptonuria - diagnosis ; Alkaptonuria - diet therapy ; Aminoacid disorders ; Behavior ; Biological and medical sciences ; Child ; Child, Preschool ; Diet, Protein-Restricted ; Errors of metabolism ; Female ; Homogentisic Acid - urine ; Humans ; Male ; Medical sciences ; Metabolic diseases ; Patient Compliance ; Pigmentation Disorders - etiology ; Social Behavior</subject><ispartof>Journal of inherited metabolic disease, 1998-12, Vol.21 (8), p.791-798</ispartof><rights>1998 SSIEM</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3671-ca68047b02ed7e718afffcbda4f02bc78f487b14990433c62810970521a615ea3</citedby><cites>FETCH-LOGICAL-c3671-ca68047b02ed7e718afffcbda4f02bc78f487b14990433c62810970521a615ea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1674231$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9870204$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Haas, V.</creatorcontrib><creatorcontrib>Carbasius Weber, E. C.</creatorcontrib><creatorcontrib>Klerk, J. B. C.</creatorcontrib><creatorcontrib>Bakker, H. D.</creatorcontrib><creatorcontrib>Smit, G. P. A.</creatorcontrib><creatorcontrib>Huijbers, W. A. R.</creatorcontrib><creatorcontrib>Duran, M.</creatorcontrib><creatorcontrib>Poll‐The, B. T.</creatorcontrib><title>The success of dietary protein restriction in alkaptonuria patients is age‐dependent</title><title>Journal of inherited metabolic disease</title><addtitle>J Inherit Metab Dis</addtitle><description>Alkaptonuria is characterized by an increased urinary excretion of homogentisic acid, pigmentation of cartilage and connective tissues, and ultimately the development of inflammatory arthropathy. Various diets low in protein have been designed to decrease homogentisic acid excretion and to prevent the ochronotic pigmentation and arthritic lesions. However, limited information is available on the long‐term beneficial effects of these diets. We reviewed the medical records of 16 patients aged 3–27 years (4>18 years) to ascertain the age of diagnosis, growth, development, social behaviour, signs of complications and longitudinal dietary compliance. The diagnosis of alkaptonuria was made at an average age of 1.4 years (2 months–4 years); following the diagnosis all patients were prescribed a diet with a protein content of 1.5 g/kg per day. All patients showed normal growth and development, and no major complications of the disease. Behavioural problems associated with poor dietary compliance emerged as the main problem. Dietary compliance decreased progressively with age. The effect of dietary protein restriction in homogentisic acid excretion was studied by fixing the amounts of protein in the diet at 1 g/kg per day and 3.5–5 g/kg per day during 8 days. Twelve patients, aged 4–27 years, participated in the investigation. Protein restriction resulted in a significantly lower excretion of homogentisic acid in the urine of children younger than 12 years (p<0.01), whereas this effect was less obvious for adolescent and adult patients. The results suggest that restriction of protein intake may have a beneficial effect on alkaptonuric children; but continuation of this regimen to older age seems questionable and not practical.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aging</subject><subject>Alkaptonuria - complications</subject><subject>Alkaptonuria - diagnosis</subject><subject>Alkaptonuria - diet therapy</subject><subject>Aminoacid disorders</subject><subject>Behavior</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Diet, Protein-Restricted</subject><subject>Errors of metabolism</subject><subject>Female</subject><subject>Homogentisic Acid - urine</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Patient Compliance</subject><subject>Pigmentation Disorders - etiology</subject><subject>Social Behavior</subject><issn>0141-8955</issn><issn>1573-2665</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkM9u1EAMxkcIVLaFMyekOSBuofZk_oXbqrRQVMSlcI0mEw8MZJMwkwj11kfoM_IkDNoViFNPlu2fP9sfY88QXiGI-nT7GgGURJCopRUP2AaVqSuhtXrINoASK9so9Zgd5_wNABqr1BE7aqwBAXLDPl9_JZ5X7ylnPgXeR1pcuuFzmhaKI0-UlxT9EqeRl9QN3928TOOaouOzWyKNS-Yxc_eFft3e9TTT2JfaE_YouCHT00M8YZ8uzq_P3lVXH99enm2vKl9rg5V32oI0HQjqDRm0LoTgu97JAKLzxgZpTYeyaUDWtdfCIjQGlECnUZGrT9jLvW6598dabm13MXsaBjfStOZWN4iojSrg6R70aco5UWjnFHfl0xah_eNku23_c7JMPD9Ir92O-r_8wbrSf3Hou-zdEJIbfcz_ZLWRosaCqT32Mw50c9_W9v3lhzdgGqx_AzXlizA</recordid><startdate>199812</startdate><enddate>199812</enddate><creator>Haas, V.</creator><creator>Carbasius Weber, E. C.</creator><creator>Klerk, J. B. C.</creator><creator>Bakker, H. D.</creator><creator>Smit, G. P. A.</creator><creator>Huijbers, W. A. R.</creator><creator>Duran, M.</creator><creator>Poll‐The, B. T.</creator><general>Kluwer Academic Publishers</general><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199812</creationdate><title>The success of dietary protein restriction in alkaptonuria patients is age‐dependent</title><author>Haas, V. ; Carbasius Weber, E. C. ; Klerk, J. B. C. ; Bakker, H. D. ; Smit, G. P. A. ; Huijbers, W. A. R. ; Duran, M. ; Poll‐The, B. T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3671-ca68047b02ed7e718afffcbda4f02bc78f487b14990433c62810970521a615ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aging</topic><topic>Alkaptonuria - complications</topic><topic>Alkaptonuria - diagnosis</topic><topic>Alkaptonuria - diet therapy</topic><topic>Aminoacid disorders</topic><topic>Behavior</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Diet, Protein-Restricted</topic><topic>Errors of metabolism</topic><topic>Female</topic><topic>Homogentisic Acid - urine</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Patient Compliance</topic><topic>Pigmentation Disorders - etiology</topic><topic>Social Behavior</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Haas, V.</creatorcontrib><creatorcontrib>Carbasius Weber, E. C.</creatorcontrib><creatorcontrib>Klerk, J. B. C.</creatorcontrib><creatorcontrib>Bakker, H. D.</creatorcontrib><creatorcontrib>Smit, G. P. A.</creatorcontrib><creatorcontrib>Huijbers, W. A. R.</creatorcontrib><creatorcontrib>Duran, M.</creatorcontrib><creatorcontrib>Poll‐The, B. T.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of inherited metabolic disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haas, V.</au><au>Carbasius Weber, E. C.</au><au>Klerk, J. B. C.</au><au>Bakker, H. D.</au><au>Smit, G. P. A.</au><au>Huijbers, W. A. R.</au><au>Duran, M.</au><au>Poll‐The, B. T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The success of dietary protein restriction in alkaptonuria patients is age‐dependent</atitle><jtitle>Journal of inherited metabolic disease</jtitle><addtitle>J Inherit Metab Dis</addtitle><date>1998-12</date><risdate>1998</risdate><volume>21</volume><issue>8</issue><spage>791</spage><epage>798</epage><pages>791-798</pages><issn>0141-8955</issn><eissn>1573-2665</eissn><coden>JIMDDP</coden><abstract>Alkaptonuria is characterized by an increased urinary excretion of homogentisic acid, pigmentation of cartilage and connective tissues, and ultimately the development of inflammatory arthropathy. Various diets low in protein have been designed to decrease homogentisic acid excretion and to prevent the ochronotic pigmentation and arthritic lesions. However, limited information is available on the long‐term beneficial effects of these diets. We reviewed the medical records of 16 patients aged 3–27 years (4>18 years) to ascertain the age of diagnosis, growth, development, social behaviour, signs of complications and longitudinal dietary compliance. The diagnosis of alkaptonuria was made at an average age of 1.4 years (2 months–4 years); following the diagnosis all patients were prescribed a diet with a protein content of 1.5 g/kg per day. All patients showed normal growth and development, and no major complications of the disease. Behavioural problems associated with poor dietary compliance emerged as the main problem. Dietary compliance decreased progressively with age. The effect of dietary protein restriction in homogentisic acid excretion was studied by fixing the amounts of protein in the diet at 1 g/kg per day and 3.5–5 g/kg per day during 8 days. Twelve patients, aged 4–27 years, participated in the investigation. Protein restriction resulted in a significantly lower excretion of homogentisic acid in the urine of children younger than 12 years (p<0.01), whereas this effect was less obvious for adolescent and adult patients. The results suggest that restriction of protein intake may have a beneficial effect on alkaptonuric children; but continuation of this regimen to older age seems questionable and not practical.</abstract><cop>Dordrecht</cop><pub>Kluwer Academic Publishers</pub><pmid>9870204</pmid><doi>10.1023/A:1005410416482</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0141-8955 |
ispartof | Journal of inherited metabolic disease, 1998-12, Vol.21 (8), p.791-798 |
issn | 0141-8955 1573-2665 |
language | eng |
recordid | cdi_proquest_miscellaneous_69111675 |
source | Wiley-Blackwell Read & Publish Collection; Springer Nature - Connect here FIRST to enable access |
subjects | Adolescent Adult Aging Alkaptonuria - complications Alkaptonuria - diagnosis Alkaptonuria - diet therapy Aminoacid disorders Behavior Biological and medical sciences Child Child, Preschool Diet, Protein-Restricted Errors of metabolism Female Homogentisic Acid - urine Humans Male Medical sciences Metabolic diseases Patient Compliance Pigmentation Disorders - etiology Social Behavior |
title | The success of dietary protein restriction in alkaptonuria patients is age‐dependent |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T10%3A59%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20success%20of%20dietary%20protein%20restriction%20in%20alkaptonuria%20patients%20is%20age%E2%80%90dependent&rft.jtitle=Journal%20of%20inherited%20metabolic%20disease&rft.au=Haas,%20V.&rft.date=1998-12&rft.volume=21&rft.issue=8&rft.spage=791&rft.epage=798&rft.pages=791-798&rft.issn=0141-8955&rft.eissn=1573-2665&rft.coden=JIMDDP&rft_id=info:doi/10.1023/A:1005410416482&rft_dat=%3Cproquest_cross%3E69111675%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3671-ca68047b02ed7e718afffcbda4f02bc78f487b14990433c62810970521a615ea3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69111675&rft_id=info:pmid/9870204&rfr_iscdi=true |